BioScience Health Innovations, Inc.
Raising nowPublicSoftware & AI · Bluffdale, UT
BioScience Health Innovations sells over-the-counter health and wellness products online and through other distribution channels. Its line includes mouth and nasal sprays, a surface cleaner, and brain-support supplements, some containing methylene blue, aimed at fighting bacteria and viruses and supporting mental wellness.
This company has an open fundraising round.
Financials
FY2019–FY2025 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Jul 6, 2026| Class | Outstanding | Votes / share | Converts | As converted | Last price |
|---|---|---|---|---|---|
| Series Apreferred | 140,000 | — | 3 × common stock | 3.42% | — |
| Preferred stockpreferred(as of Jun 30, 2026) | 140,000 | — | — | 1.14% | — |
| Common stock | 11,714,004 | 1 | — | 95.4% | $1.00Dec 2025 |
| Total | 11,994,004 | 12,274,004 as converted | 100% |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Ageless Holdings LLC7.2M (16.3%) Mar 2025 → 1.8M (642.5%) Nov 2025
- Dan Schmidt5.0M (11.3%) Mar 2025 → 1.3M (446.4%) Nov 2025 → 1.0M (8.55%) Mar 2026
- Darren Lopez4.4M (10.1%) Mar 2025 → 2.9M (1038.8%) Nov 2025 → 2.9M (24.9%) Mar 2026
- John Chymboryk1.8M (4.03%) Mar 2025 → 444K (158.5%) Nov 2025
- Justin Earl2.8M (2800.0%) Nov 2021 → 700K (250.0%) Nov 2025
Principal holders% as the filing states it, Mar 30, 2026
- Darren Lopez2,908,751 Common Stock26.5%of company
- Ageless Holdings LLC1,799,063 Common Stock16.4%of company
- Dan Schmidt1,000,000 Common Stock9.11%of company
- Justin Earl700,000 Common Stock6.38%of company
- John Chymboryk443,750 Common Stock4.04%of company
- Everyone else (not named in filings)37.6%
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. “As converted” counts each class in the shares it converts into. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
4 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 34 filings on EDGAR- Form 10-QAug 7, 20260001096906-26-001173EDGAR
- Form QUALIFJul 9, 20269999999994-26-000135EDGAR
- Form 1-A POSJul 6, 20260001096906-26-001058EDGAR
- Form 10-QMay 11, 20260001185185-26-001775EDGAR
- Form 10-KMar 30, 20260001185185-26-001133EDGAR
- Form QUALIFDec 4, 20259999999994-25-000216EDGAR
- Form 1-ANov 25, 20250001185185-25-001854EDGAR
- Form 10-QOct 27, 20250001185185-25-001545EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.